CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 199 filers reported holding CLOVIS ONCOLOGY INC in Q3 2015. The put-call ratio across all filers is 0.94 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $178,000 | -41.1% | 99,358 | -33.7% | 0.00% | – |
| Q1 2022 | $302,000 | +224.7% | 149,844 | +333.8% | 0.00% | – |
| Q4 2021 | $93,000 | +615.4% | 34,541 | +1345.2% | 0.00% | – |
| Q3 2021 | $13,000 | 0.0% | 2,390 | +4.4% | 0.00% | – |
| Q2 2021 | $13,000 | -95.3% | 2,290 | -94.2% | 0.00% | -100.0% |
| Q1 2021 | $279,000 | +27800.0% | 39,755 | +13151.7% | 0.00% | – |
| Q4 2020 | $1,000 | -99.9% | 300 | -99.6% | 0.00% | -100.0% |
| Q2 2019 | $992,000 | +17.3% | 66,740 | +95.8% | 0.00% | +50.0% |
| Q1 2019 | $846,000 | -42.8% | 34,090 | -58.6% | 0.00% | -50.0% |
| Q4 2018 | $1,478,000 | +46.6% | 82,311 | +139.8% | 0.00% | +33.3% |
| Q3 2018 | $1,008,000 | +100.0% | 34,327 | +209.3% | 0.00% | +50.0% |
| Q2 2018 | $504,000 | -44.1% | 11,100 | -35.1% | 0.00% | -95.0% |
| Q1 2018 | $902,000 | -69.0% | 17,102 | -60.0% | 0.04% | -68.0% |
| Q4 2017 | $2,907,000 | +28.7% | 42,752 | +56.0% | 0.12% | +35.9% |
| Q3 2017 | $2,258,000 | +498.9% | 27,403 | +580.0% | 0.09% | +475.0% |
| Q2 2017 | $377,000 | -85.7% | 4,030 | -90.3% | 0.02% | -86.0% |
| Q1 2017 | $2,634,000 | +550.4% | 41,373 | +353.3% | 0.11% | +375.0% |
| Q4 2016 | $405,000 | -54.8% | 9,127 | -63.3% | 0.02% | -60.7% |
| Q3 2016 | $897,000 | +134.8% | 24,883 | +25.0% | 0.06% | +103.3% |
| Q1 2016 | $382,000 | +118.3% | 19,909 | +296.5% | 0.03% | +114.3% |
| Q4 2015 | $175,000 | +78.6% | 5,021 | +371.0% | 0.01% | +100.0% |
| Q3 2015 | $98,000 | +308.3% | 1,066 | +279.4% | 0.01% | +250.0% |
| Q2 2015 | $24,000 | – | 281 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |